NADH oxidation is highly exergonic – it releases a large amount of energy.
ADP rephosphorylation (forming ATP) is only moderately endergonic.
This difference allows energy from NADH oxidation to power ATP synthesis via proton-motive force.
PMF is generated by the oxidation of NADH and FADH2.
It is a proton gradient across the inner mitochondrial membrane = pH difference.
PMF drives ATP synthesis by powering ATP synthase.
Experimental evidence supports the PMF model.
ATP synthase = Complex V, also called:
Mitochondrial ATPase
F1F0 ATPase
Resembles a ball-and-stick model:
F0 ("stick"): proton channel, embedded in membrane.
F1 ("ball"): catalytic, extends into matrix.
Components:
F1 Subunit:
Catalytic unit; α₃β₃γδε.
Three β subunits = active sites.
γ subunit connects to F0, breaks symmetry.
F0 Subunit:
Proton-conducting unit; a, b, c subunits.
C-ring (8–14 c subunits, species dependent).
Stabilized by dimerization → aids cristae formation.
γε central stalk = rotor
γ = coiled coil, rotates within α₃β₃ hexamer.
Stator = exterior column:
Composed of a subunit, 2 b subunits, δ subunit.
Catalysis occurs in β subunits through conformational cycling:
O (open): nucleotides bind/release.
L (loose): ADP + Pi held in place.
T (tight): ATP formed from ADP + Pi.
Without proton flow, ATP cannot be released.
Rotation of γ subunit (powered by c-ring):
Converts T → O → L → T by 120° steps.
Drives ATP release and ADP/Pi binding.
F0’s a subunit has two half-channels:
One opens to intermembrane space, the other to matrix.
Proton flow mechanism:
Proton enters from intermembrane space → neutralizes c-subunit aspartate.
C-ring rotates, releasing a different proton to the matrix.
Cycle continues; each proton drives one step of rotation.
One full 360° rotation = 3 ATP formed.
In yeast: 10 c-subunits → 10 H+ for 3 ATP → ~3.33 H+ per ATP.
In humans: 8 c-subunits → ~2.7 H+ per ATP → more efficient.
Proton pumping by ETC complexes:
Complex I: 4 H⁺
Complex III: 2 H⁺
Complex IV: 4 H⁺
~2.5 ATP per NADH (after factoring in ATP/ADP transport cost).
ATP-ADP translocase exchanges cytoplasmic ADP for mitochondrial ATP.
Accounts for ~15% of inner membrane proteins.
ATP has more negative charge than ADP → movement aligns with membrane potential.
Exchange costs ~1 H+ → 25% of PMF is used here.
ATP-ADP translocase: three 100-AA domains, each with 2 transmembrane segments.
Phosphate carrier: exchanges H₂PO₄⁻ for OH⁻ → net cost = 1 H⁺ per ADP import.
~30 ATP per glucose; 26 from oxidative phosphorylation, 4 from glycolysis.
ADP availability controls ETC → “Respiratory (Acceptor) Control”.
No ADP = No electron flow through ETC.
ATP synthesis requires:
Intact inner membrane
Impermeability to ions
Electrochemical proton gradient
Artificial PMF can drive ATP synthesis even without ETC.
PMF used in:
Ca²⁺ active transport
Sugar/amino acid import in bacteria
NADPH synthesis (photosynthesis)
Flagella motion (bacterial propulsion)
Heat generation (thermogenesis)
IF1 (Inhibitory Factor 1):
Inhibits ATP synthase hydrolysis mode when O₂ is limited.
Overexpressed in some cancers.
UCP-1 (thermogenin):
In brown adipose tissue (BAT), causes nonshivering thermogenesis.
UCP-2/3 involved in energy regulation, may affect body weight.
BAT is active in cold exposure and hibernation.
Three major inhibition routes:
ETC inhibition → no PMF
ATP synthase inhibition
Uncoupling (e.g. 2,4-dinitrophenol) → protons bypass synthase.
Key inhibitors:
Rotenone, amytal: block Complex I → ubiquinone.
Antimycin A: blocks Complex III.
Cyanide, azide, CO: block Complex IV.
Complex I dysfunction is most common.
Defects → ↓ ATP + ↑ reactive oxygen species (ROS) → mitochondrial damage.
Mitochondria mediate apoptosis (programmed cell death).
Upon outer membrane permeabilization, cytochrome c is released → activates caspase cascade → cell death.
Vital in development, tissue remodeling, and removal of damaged cells.